Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 12Non-Muscle Invasive Bladder Neoplasms 9Carcinoma, Transitional Cell 7Stomach Neoplasms 4Anus Neoplasms 4Pancreatic Neoplasms 3Carcinoma, Hepatocellular 3Peritoneal Neoplasms 2Liver Neoplasms 2Colorectal Neoplasms 2Appendiceal Neoplasms 2Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1Urinary Bladder Diseases 1Urethral Neoplasms 1Ureteral Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pseudomyxoma Peritonei 1Neoplasms by Site 1Neoplasms 1Neoplasm Recurrence, Local 1Neoplasm Metastasis 1Mycobacterium Infections 1Gastrointestinal Neoplasms 1Dermatitis 1Carcinoma in Situ 1Carcinoma 1Anal Canal Carcinoma 1Adenocarcinoma 1

Interventions

Fluorouracil 3Radiotherapy 2Cisplatin 2Cetuximab 2rocakinogene sifuplasmid 1durvalumab 1VGX-3100 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Nivolumab 1Mitomycin 1Magnetic Resonance Spectroscopy 1MEDI0457 1Ipilimumab 1Immunoglobulin G 1Disulfides 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Anal Canal Carcinoma × Mitomycin × Clear all
NCT00423293 2019-02-27

Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer

Radiation Therapy Oncology Group

Phase 2 Completed
63 enrolled 15 charts
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡